Imaginet Competitors

Cimpress plc (Nasdaq: CMPR) invests in and builds customer-focused, entrepreneurial, mass-customization businesses for the long term. Mass customization is a competitive strategy which seeks to produce goods and services to meet individual customer needs with near mass production efficiency. Cimpress is a strategically-focused group of more than a dozen businesses, each operating in a largely autonomous manner other than as it relates to the select few shared strategic and corporate activities that we maintain centrally. Cimpress businesses include Drukwerkdeal, Exaprint, National Pen, Pixartprinting, Printi, Vistaprint and WIRmachenDRUCK. Founded by Robert Keane, who remains President & CEO today, the company has been passionate about empowering people to make an impression through individually meaningful, personalized physical products for more than 20 years. To learn more, visit http://www.cimpress.com.

We design technology that is built to scale. Our proprietary development processes guarantee reliable, user-centered solutions that drive seamless digital transformation for Enterprise and Scale-up companies. That is what we call seamless technology. We have helped many customers achieve growth such as Nokia, Thermo-Fisher, and BNP Paribas. Over the last 13 years, with more than 300 projects developed, we have gathered several awards such as Financial Times 1000: Europe's Fastest Growing Companie 2023 & 2024, Top 100 Fastest Growing Companies, Top 1000 Global Companies in 2020 & 2021, UK Top B2B Company in 2021 & 2022, and Europe Best Workplace® 2022. Our services: - Product Ideation: Scoping Session, Product Development Process, MVP, Digital Transformation - Product Development: Software Development, Web Development, Mobile Development, Artificial Intelligence, UX/UI Design, Quality Assurance - Product Improvement: Code Audit, UX Audit, Digital Acceleration - Artificial Intelligence: AI Development, AI PoC, Machine Learning, Data Engineering Our tech stack: - Front & Back end: .Net, React, Next.JS, Angular, Due, Webflow, Node, Python, Rails, Django - Mobile: React Native, Flutter - Systems: AWS, Azure, Google Cloud Why us? - Built to scale. - Digital acceleration with a lean mindset. - Human-Centric. - Highly process-oriented. - Technical Excellency. - Work with the 1%. - Full transparency. - Partner & advisor.

At Thriva, we’re on a mission to help millions of people worldwide become actively invested in their long term health. Through using health insights to help them thrive. Our consumer business is for everyone who wants to improve and understand what is happening inside their bodies. From taking a home test to getting actionable results and GP advice all through a website and app. Our B2B business, Thriva Solutions offers health services and provides a full end to end diagnostic service (DAAS). We offer speed, reduced risk and scaling of diagnostic capabilities for partners who work with us. We’re building a new category in the market and would love for you to come on this journey with us. We’ve sent over 5 million test kits to hundreds of thousands of customers, giving them insights into their health, measuring things like nutrients, hormones, cholesterol, and also have an exciting clinical innovation pipeline, where we’re constantly looking to bring in new tests and testing modalities, such as sexual health screens, genetic testing, and urine testing. With Thriva, you get: - Personalised blood tests - GP-reviewed results in 48 hours - Evidence-based advice Check your health as often as you like with our flexible subscription tests. We offer everything from monthly to annual options. And you can change, pause, delay, or cancel at any time. How does it work? 1. Collect your sample — we’ll show you all the tips and tricks on how to collect your sample. 2. Label and post — send your sample and get results straight to the app within 48 hours. 3. Get personalised insights — understand how your lifestyle habits and blood test results can affect your health and how to improve it. We never share or sell your medical information with third parties.